Imaging Lymphatic Function in Normal Subjects and in Persons With Lymphatic Disorders

UnknownOBSERVATIONAL
Enrollment

283

Participants

Timeline

Start Date

January 31, 2009

Primary Completion Date

December 31, 2019

Study Completion Date

June 30, 2020

Conditions
LymphedemaLymphatic DisordersLipedemaVascular MalformationVascular AnomalyDercum Disease
Interventions
DRUG

NIRFLI with ICG

We conduct Near-infrared Fluorescence Lymphatic Imaging following the off-label use of Indocyanine Green as a lymph contrast agent and the use of a custom designed fluorescence imager to dynamically follow lymphatic trafficking in subjects. We seek to use the resulting phenotypes acquired in normal and diseased patients to correlate to mutations of specific genes reported to be associated with lymphatic development.

Trial Locations (3)

77030

Lymphedema Clinic at Memorial Hermann Hospital in the Texas Medical Center, Houston

UT Physicians Pediatric Surgery Clinic, Houston

77384

Wound Care Clinic at CHI St. Luke's The Woodland's Hospital, The Woodlands

Sponsors

Collaborators (1)

All Listed Sponsors
collaborator

National Heart, Lung, and Blood Institute (NHLBI)

NIH

collaborator

National Cancer Institute (NCI)

NIH

collaborator

Lymphatic Malformation Institute

OTHER

collaborator

Lipedema Foundation

OTHER

lead

The University of Texas Health Science Center, Houston

OTHER